Rare diseases
Investigational molecules
Locations
Back to Belgium1 932 clinical trials in Edegem, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy
BelgiumStudy on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus
BelgiumStudy on Ceftriaxone Dosing for Patients with Severe Community-Acquired Pneumonia
BelgiumStudy on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer
The NetherlandsStudy on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus
BelgiumStudy on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma
BelgiumStudy on Indocyanine Green for Evaluating Surgical Margins in Patients Undergoing Breast-Conserving Surgery for Early Invasive Breast Cancer
BelgiumStudy on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
BelgiumStudy on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2
BelgiumStudy on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer
BelgiumStudy on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1
BelgiumStudy of Amivantamab and Chemotherapy Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on viral infections and vaccine development, including studies for influenza, RSV, and COVID-19. Multiple trials are evaluating immune responses and vaccine efficacy in different age groups.
Special attention is given to vulnerable populations, including elderly adults and pregnant women.
Innovative studies addressing Primary Biliary Cholangitis and Hepatitis D treatments. Research includes evaluation of novel therapeutics and their impact on disease progression.
Trials focus on improving patient outcomes and developing targeted treatments.
Advanced research in breast cancer and lung cancer treatments, exploring new therapeutic combinations and targeted approaches for better patient outcomes.
Focus on personalized medicine approaches and innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
